Mutation-based structural modification and dynamics study of amyloid beta peptide (1–42): An in-silico-based analysis to cognize the mechanism of aggregation
Alzheimer's disease is the prevalent cause of premature senility, a progressive mental disorder due to degeneration in brain and deposition of amyloid β peptide (1–42, a misfolded protein) in the form of aggregation that prevails for a prolonged time and obstructs every aspect of life. One of t...
Main Authors: | Pritam Kumar Panda, Abhaysinha Satish Patil, Priyam Patel, Hetalkumar Panchal, Dr. |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Genomics Data |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213596016300010 |
Similar Items
-
Aggregation studies of the beta (34-42) peptide and synthesis of targets for amyloid staining and imaging
by: May, Christopher L. (Christopher Laurence)
Published: (2008) -
In silico study of traditional Chinese medicinal compounds targeting alzheimer's disease amyloid beta-peptide (1–42)
by: V. Naveen Kumar, et al.
Published: (2023-12-01) -
Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: O. Elaskalani, et al.
Published: (2018-05-01) -
Hypochlorite-induced oxidation promotes aggregation and reduces toxicity of amyloid beta 1-42
by: Noralyn B. Mañucat-Tan, et al.
Published: (2023-07-01) -
Differential effects of NSAIDs on amyloid β1-42 peptide aggregation
by: Atheer Al-Zurfi, et al.
Published: (2019-05-01)